Evoq Remedies shareholders and shareholding pattern
BSE: 543500Commercial Services & SuppliesSmall Cap
Evoq Remedies Limited · Face value ₹10 Face value. The nominal value of one share as the company issued it, the unit its share capital is counted in and a dividend can be stated as a percentage of; it has no link to the share price. Face value in the glossary · Listed Mar 2022
Last close ₹1.61down ₹0.08 (4.73%)
Share price at the BSE close on 28 Oct 2026. Previous close ₹1.69.
28 Oct: open ₹1.69, high ₹1.69, low ₹1.61
52-week range of traded prices to 28 Oct 2026
₹1.35Low, 22 Sep 2026₹6.04High, 28 Oct 2025
- Market capMarket capitalisation. Share price times the number of shares: what the whole company is worth at the day's price. The rank is by average market value over the six months to Jun 2026, among listed companies. Market capitalisation: how it is worked out
- ₹4.01 Cr4,812th largest listed
- P/EPrice to earnings, trailing. Market cap divided by the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, after the share of the other owners of its subsidiaries: what investors pay for each rupee of a year's profit. Price to earnings, trailing: how it is worked out
- Lossover the last 12 months
- P/BPrice to book. Market cap divided by the net worth that belongs to the company's own shareholders, its assets less everything it owes and less the other owners' share of its subsidiaries, on its latest balance sheet. Price to book: how it is worked out
- 0.09
- Dividend yieldDividend yield. Dividends paid per share in the twelve months to the day, as a percentage of the day's share price.
- Nonein the last 12 months
- ROEReturn on equity. Profit over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, as a percentage of their net worth, the money they have in the business. Net worth is the average of the latest balance sheet and the one a year before it.
- −0.5%
- Debt to equityDebt to equity. Borrowings divided by the whole group's net worth, the other owners of its subsidiaries included: rupees borrowed for each rupee of equity in the business. Lease liabilities are not counted: the results filings do not state them. From the balance sheet at the end of Mar 2026.
- 0.00
- Volume, BSEVolume. Shares traded on the last trading day. Volume in the glossary
- 28,000
Evoq Remedies' shareholding pattern for Mar 2026, filed on 11 May 2026: who owns its shares by group, its promoters by name and its public holders of 1% or more.
Who owns Evoq Remedies, filing by filing
Per cent of the company's shares.
31 Mar 2026 filing
- Promoters0.02%
- Individuals and others99.98%
| Per cent | Mar 202631 Mar |
|---|---|
| 0.02% | |
| Indian promoters | 0.02% |
| Public. Every shareholder outside the promoter group, the employee trusts and the shares held against depositary receipts, as the filing totals them. Public in the glossary | 99.98% |
| Shares in issue | 2,49,00,000 |
A dash is a line the filing did not state.
Evoq Remedies promoters
Promoters are the founders, families and companies that control the company, as its filings name them. Every member of the promoter group holding shares in the filing of 31 Mar 2026; the largest is BHUMISHTH NARENDRABHAI PATEL, 0.01%.Promoter buying and selling
| Holder | ||
|---|---|---|
| BHUMISHTH NARENDRABHAI PATELIndividuals and Hindu undivided families | 0.01% | 3,574 |
| PATEL PAYAL BHUMISHTHIndividuals and Hindu undivided families | 0.00% | 71 |
| SUSHILABAHEN NARENDRAKUMAR PATELIndividuals and Hindu undivided families | 0.00% | 71 |
| AUXILIA PHARMACEUTICALS PRIVATE LIMITEDIndian companies, trusts and others | 0.00% | 71 |
| NARENDRAKUMAR GANGARAMDAS PATELIndividuals and Hindu undivided families | 0.00% | 71 |
| DAHYABHAI MAFATLAL PATELIndividuals and Hindu undivided families | 0.00% | 71 |
No promoter shares are reported as pledged.
Largest public holders of Evoq Remedies, filing by filing
Per cent, on the same shares as the split above.
| Holder | Mar 202631 Mar |
|---|---|
| DHRUV GANJIResident individuals, over ₹2 lakh at face value | 11.35% |
| PRASHANT SEVANTIKARResident individuals, over ₹2 lakh at face value | 11.35% |
| SURYA PRAKASH JETHLIAResident individuals, over ₹2 lakh at face value | 2.62% |
| NILESH M SUHAGIYAResident individuals, over ₹2 lakh at face value | 2.09% |
| ANAND MOHANResident individuals, over ₹2 lakh at face value | 1.53% |
| YASHIV HOLDINGS PRIVATE LIMITEDCompanies | 1.46% |
| PATTABIRAMAN N RResident individuals, over ₹2 lakh at face value | 1.40% |
| AMBALAL KARAMSHIBHAI SENGHANINon-resident Indians | 1.04% |
| GAYATHRI RADHAKRISHNANResident individuals, over ₹2 lakh at face value | 1.04% |
A filing names every holder above one per cent, in the company's own words: an insurer's holding can carry one of its funds' names. A dash is a filing that did not name the holder, which includes holding under one per cent.
Who moved in the Mar 2026 filing
Against the Sep 2025 filing. A filing names a public holder only at 1% or more, so a holder no longer named fell under 1% or sold out.
- Individuals and others: SURYA PRAKASH JETHLIA newly named at 2.62%; NILESH M SUHAGIYA newly named at 2.09%; PATTABIRAMAN N R newly named at 1.40%; 3 more moved